

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of chronic inflammatory response (GO:0002676) | 9.01008112 |
| 2 | tryptophan catabolic process (GO:0006569) | 8.57802443 |
| 3 | indole-containing compound catabolic process (GO:0042436) | 8.57802443 |
| 4 | indolalkylamine catabolic process (GO:0046218) | 8.57802443 |
| 5 | single fertilization (GO:0007338) | 8.52454001 |
| 6 | heterotypic cell-cell adhesion (GO:0034113) | 8.45395031 |
| 7 | B cell receptor signaling pathway (GO:0050853) | 7.84886507 |
| 8 | negative regulation of interleukin-10 production (GO:0032693) | 7.38676994 |
| 9 | positive regulation of type 2 immune response (GO:0002830) | 7.38504108 |
| 10 | tryptophan metabolic process (GO:0006568) | 7.38216984 |
| 11 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 7.04800322 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.98891976 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 5.92818309 |
| 14 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 5.83999509 |
| 15 | defense response to protozoan (GO:0042832) | 5.78738397 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.65327663 |
| 17 | fertilization (GO:0009566) | 5.61898617 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.59103750 |
| 19 | amine catabolic process (GO:0009310) | 5.51977833 |
| 20 | cellular biogenic amine catabolic process (GO:0042402) | 5.51977833 |
| 21 | indolalkylamine metabolic process (GO:0006586) | 5.41366459 |
| 22 | regulation of germinal center formation (GO:0002634) | 5.28986448 |
| 23 | negative regulation of interleukin-8 production (GO:0032717) | 5.20695879 |
| 24 | regulation of antigen processing and presentation (GO:0002577) | 5.13768825 |
| 25 | positive thymic T cell selection (GO:0045059) | 4.92343660 |
| 26 | benzene-containing compound metabolic process (GO:0042537) | 4.84508642 |
| 27 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.81340924 |
| 28 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.81340924 |
| 29 | response to protozoan (GO:0001562) | 4.78227985 |
| 30 | positive regulation of Rap GTPase activity (GO:0032854) | 4.74923721 |
| 31 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.70681520 |
| 32 | digestion (GO:0007586) | 4.58550926 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.52898270 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.47102990 |
| 35 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 4.46214496 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.39660899 |
| 37 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.37488273 |
| 38 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.36782308 |
| 39 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.34577407 |
| 40 | epithelial cell morphogenesis (GO:0003382) | 4.34012698 |
| 41 | negative regulation of T cell apoptotic process (GO:0070233) | 4.33028500 |
| 42 | negative regulation of endopeptidase activity (GO:0010951) | 4.32760494 |
| 43 | respiratory burst (GO:0045730) | 4.28764689 |
| 44 | aromatic amino acid family metabolic process (GO:0009072) | 4.28679058 |
| 45 | positive regulation of cell-cell adhesion (GO:0022409) | 4.28655274 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 4.26995738 |
| 47 | histone H3-K36 demethylation (GO:0070544) | 4.22190216 |
| 48 | immunoglobulin mediated immune response (GO:0016064) | 4.19975328 |
| 49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.19684626 |
| 50 | negative regulation of peptidase activity (GO:0010466) | 4.13325147 |
| 51 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.10974206 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.08131591 |
| 53 | negative regulation of cell killing (GO:0031342) | 4.08131591 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 4.07812902 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.06804737 |
| 56 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.06383961 |
| 57 | regulation of Rap GTPase activity (GO:0032317) | 4.01390548 |
| 58 | positive regulation of mast cell degranulation (GO:0043306) | 3.99750671 |
| 59 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.99750671 |
| 60 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.95636863 |
| 61 | regulation of B cell differentiation (GO:0045577) | 3.95075964 |
| 62 | transepithelial transport (GO:0070633) | 3.95070274 |
| 63 | detection of bacterium (GO:0016045) | 3.92337540 |
| 64 | B cell homeostasis (GO:0001782) | 3.90586158 |
| 65 | positive regulation of chemokine secretion (GO:0090197) | 3.89503045 |
| 66 | indole-containing compound metabolic process (GO:0042430) | 3.87370537 |
| 67 | reactive oxygen species biosynthetic process (GO:1903409) | 3.87206047 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.85801140 |
| 69 | regulation of type 2 immune response (GO:0002828) | 3.84271621 |
| 70 | positive regulation of antigen processing and presentation (GO:0002579) | 3.82582262 |
| 71 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.74923052 |
| 72 | reverse cholesterol transport (GO:0043691) | 3.73957978 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.72540724 |
| 74 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.72110812 |
| 75 | positive T cell selection (GO:0043368) | 3.68339730 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 3.67959482 |
| 77 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.66154312 |
| 78 | sulfur amino acid catabolic process (GO:0000098) | 3.65675735 |
| 79 | detection of other organism (GO:0098543) | 3.63648649 |
| 80 | protein-chromophore linkage (GO:0018298) | 3.61194626 |
| 81 | regulation of platelet aggregation (GO:0090330) | 3.60944268 |
| 82 | positive regulation of B cell proliferation (GO:0030890) | 3.58520524 |
| 83 | thymic T cell selection (GO:0045061) | 3.53260226 |
| 84 | defense response to bacterium (GO:0042742) | 3.51464628 |
| 85 | multicellular organism reproduction (GO:0032504) | 3.49608405 |
| 86 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.45029622 |
| 87 | activation of Rac GTPase activity (GO:0032863) | 3.44456055 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 3.41186610 |
| 89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.40856680 |
| 90 | B cell proliferation (GO:0042100) | 3.40302727 |
| 91 | regulation of gamma-delta T cell activation (GO:0046643) | 3.39351594 |
| 92 | T cell selection (GO:0045058) | 3.38483888 |
| 93 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.36707798 |
| 94 | N-acetylneuraminate metabolic process (GO:0006054) | 3.36337438 |
| 95 | T cell costimulation (GO:0031295) | 3.31018162 |
| 96 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.30995771 |
| 97 | negative regulation of protein autophosphorylation (GO:0031953) | 3.30373144 |
| 98 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.29309134 |
| 99 | regulation of chemokine secretion (GO:0090196) | 3.29008695 |
| 100 | positive regulation of B cell activation (GO:0050871) | 3.27804587 |
| 101 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.26338710 |
| 102 | lymphocyte costimulation (GO:0031294) | 3.25943477 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.25294027 |
| 104 | positive regulation of interferon-alpha production (GO:0032727) | 3.24565672 |
| 105 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.21784514 |
| 106 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.21734573 |
| 107 | neutrophil activation (GO:0042119) | 3.18827424 |
| 108 | alpha-linolenic acid metabolic process (GO:0036109) | 3.17614953 |
| 109 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.17229441 |
| 110 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.16457802 |
| 111 | regulation of leukocyte degranulation (GO:0043300) | 3.16425860 |
| 112 | megakaryocyte development (GO:0035855) | 3.16069458 |
| 113 | regulation of mast cell activation (GO:0033003) | 3.13674216 |
| 114 | leukocyte aggregation (GO:0070486) | 3.13128071 |
| 115 | regulation of B cell proliferation (GO:0030888) | 3.12055945 |
| 116 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.11867045 |
| 117 | macrophage activation involved in immune response (GO:0002281) | 3.10968461 |
| 118 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.10737483 |
| 119 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.07558582 |
| 120 | superoxide anion generation (GO:0042554) | 3.07437278 |
| 121 | response to type I interferon (GO:0034340) | 3.06754353 |
| 122 | cellular response to type I interferon (GO:0071357) | 3.06276570 |
| 123 | type I interferon signaling pathway (GO:0060337) | 3.06276570 |
| 124 | response to bacterium (GO:0009617) | 3.03893173 |
| 125 | granulocyte activation (GO:0036230) | 3.03484767 |
| 126 | regulation of ARF protein signal transduction (GO:0032012) | 3.01105653 |
| 127 | regulation of macrophage activation (GO:0043030) | 3.00936675 |
| 128 | negative thymic T cell selection (GO:0045060) | 3.00085526 |
| 129 | seminiferous tubule development (GO:0072520) | 24.8672600 |
| 130 | regulation of interferon-alpha production (GO:0032647) | 2.99641042 |
| 131 | regulation of lipoprotein metabolic process (GO:0050746) | 2.99255286 |
| 132 | B cell mediated immunity (GO:0019724) | 2.98786460 |
| 133 | negative regulation of phagocytosis (GO:0050765) | 2.98095153 |
| 134 | diacylglycerol metabolic process (GO:0046339) | 2.97958229 |
| 135 | lymphocyte homeostasis (GO:0002260) | 2.96192207 |
| 136 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.94370690 |
| 137 | cysteine metabolic process (GO:0006534) | 2.81580081 |
| 138 | negative regulation of proteolysis (GO:0045861) | 2.79034828 |
| 139 | glial cell proliferation (GO:0014009) | 2.77912501 |
| 140 | complement activation, alternative pathway (GO:0006957) | 2.76756182 |
| 141 | high-density lipoprotein particle remodeling (GO:0034375) | 2.73930896 |
| 142 | regulation of beta-amyloid formation (GO:1902003) | 2.70945945 |
| 143 | regulation of activated T cell proliferation (GO:0046006) | 2.70670789 |
| 144 | sialylation (GO:0097503) | 2.70086882 |
| 145 | negative regulation of protein processing (GO:0010955) | 2.69268985 |
| 146 | negative regulation of protein maturation (GO:1903318) | 2.69268985 |
| 147 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.68960121 |
| 148 | O-glycan processing (GO:0016266) | 2.66473694 |
| 149 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.64408582 |
| 150 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.58839660 |
| 151 | low-density lipoprotein particle clearance (GO:0034383) | 2.58037226 |
| 152 | positive regulation of interleukin-12 production (GO:0032735) | 2.56247761 |
| 153 | hormone catabolic process (GO:0042447) | 2.56228775 |
| 154 | negative regulation of hydrolase activity (GO:0051346) | 2.50827653 |
| 155 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.48443869 |
| 156 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.47937243 |
| 157 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.44646377 |
| 158 | negative regulation of glycogen metabolic process (GO:0070874) | 2.44210383 |
| 159 | alpha-amino acid catabolic process (GO:1901606) | 2.39945291 |
| 160 | valine metabolic process (GO:0006573) | 2.37051814 |
| 161 | L-serine transport (GO:0015825) | 2.33527525 |
| 162 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.32073906 |
| 163 | L-phenylalanine catabolic process (GO:0006559) | 2.32073906 |
| 164 | lipid catabolic process (GO:0016042) | 2.32003550 |
| 165 | cellular amino acid catabolic process (GO:0009063) | 2.31681000 |
| 166 | regulation of endopeptidase activity (GO:0052548) | 2.31511749 |
| 167 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.28950806 |
| 168 | triglyceride catabolic process (GO:0019433) | 2.26320740 |
| 169 | negative regulation of interleukin-6 production (GO:0032715) | 2.23104470 |
| 170 | response to misfolded protein (GO:0051788) | 2.22442496 |
| 171 | protein-lipid complex remodeling (GO:0034368) | 2.21091454 |
| 172 | macromolecular complex remodeling (GO:0034367) | 2.21091454 |
| 173 | plasma lipoprotein particle remodeling (GO:0034369) | 2.21091454 |
| 174 | neutral lipid catabolic process (GO:0046461) | 2.20562865 |
| 175 | acylglycerol catabolic process (GO:0046464) | 2.20562865 |
| 176 | regulation of T cell apoptotic process (GO:0070232) | 2.20370262 |
| 177 | regulation of peptidase activity (GO:0052547) | 2.20111317 |
| 178 | cellular modified amino acid catabolic process (GO:0042219) | 2.14057644 |
| 179 | positive regulation of cholesterol transport (GO:0032376) | 2.12971255 |
| 180 | positive regulation of sterol transport (GO:0032373) | 2.12971255 |
| 181 | regulation of lipoprotein particle clearance (GO:0010984) | 2.12002405 |
| 182 | glutamate metabolic process (GO:0006536) | 2.11763982 |
| 183 | Golgi transport vesicle coating (GO:0048200) | 2.09619766 |
| 184 | COPI coating of Golgi vesicle (GO:0048205) | 2.09619766 |
| 185 | regulation of interleukin-10 production (GO:0032653) | 2.09403310 |
| 186 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.08076324 |
| 187 | L-phenylalanine metabolic process (GO:0006558) | 2.08076324 |
| 188 | myelin maintenance (GO:0043217) | 2.07618245 |
| 189 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.05422475 |
| 190 | negative regulation of T cell proliferation (GO:0042130) | 2.03275724 |
| 191 | production of molecular mediator involved in inflammatory response (GO:0002532) | 14.2129523 |
| 192 | regulation of T cell tolerance induction (GO:0002664) | 14.2123451 |
| 193 | positive regulation of tolerance induction (GO:0002645) | 12.1835489 |
| 194 | sperm capacitation (GO:0048240) | 11.0510089 |
| 195 | regulation of tolerance induction (GO:0002643) | 10.6037061 |
| 196 | kynurenine metabolic process (GO:0070189) | 10.4695998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.06333621 |
| 2 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 4.72001630 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 4.42442015 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.10397642 |
| 5 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.96199171 |
| 6 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.75103493 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.33037229 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.19973136 |
| 9 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.15597622 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.10134470 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.03131541 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.95828677 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.86832079 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.79129220 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.78156355 |
| 16 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.64917783 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.64814618 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.64602074 |
| 19 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.59846183 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.58179422 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.55021652 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.53750378 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.52658165 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.52319309 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.47397525 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43949451 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.43870066 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.38443287 |
| 29 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37475034 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 2.33289420 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 2.29089786 |
| 32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.27011034 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.26959090 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26461383 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.24011827 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 2.21772841 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.17700203 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13918299 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08755958 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 2.08239466 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.08021743 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05614085 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.05077767 |
| 44 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 2.04495976 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01022505 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.00634368 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.00213178 |
| 48 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.95750297 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94230952 |
| 50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88103652 |
| 51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.87159791 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.86211072 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84808236 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.83737966 |
| 55 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.82744188 |
| 56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.79211509 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76966587 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76236423 |
| 59 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.73844216 |
| 60 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.72051002 |
| 61 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.66653341 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66500750 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.65795530 |
| 64 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.61432053 |
| 65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.60983676 |
| 66 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.56151685 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54999562 |
| 68 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53924439 |
| 69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53769373 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.52659391 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51665265 |
| 72 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.51597023 |
| 73 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.51156718 |
| 74 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.50776284 |
| 75 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.50776284 |
| 76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50600861 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48440689 |
| 78 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.48158309 |
| 79 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.47639367 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46290827 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45636503 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45498948 |
| 83 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.45099953 |
| 84 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43436837 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42107298 |
| 86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.38219051 |
| 87 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37321842 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36846926 |
| 89 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.36562899 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36423564 |
| 91 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32396967 |
| 92 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.31491987 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31402766 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29710283 |
| 95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.29561939 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28163149 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27791582 |
| 98 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.27264640 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.26692783 |
| 100 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.26202989 |
| 101 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.25986378 |
| 102 | SA1_27219007_Chip-Seq_Bcells_Human | 1.25952043 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25839102 |
| 104 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24605268 |
| 105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22349383 |
| 106 | P68_20966046_ChIP-Seq_HELA_Human | 1.21806734 |
| 107 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21665283 |
| 108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21261644 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20111166 |
| 110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19733840 |
| 111 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.18046679 |
| 112 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17456064 |
| 113 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.17021429 |
| 114 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.15513324 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15200819 |
| 116 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14352787 |
| 117 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13879308 |
| 118 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13105418 |
| 119 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.12795411 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11441412 |
| 121 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 1.10999943 |
| 122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.10545638 |
| 123 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10334267 |
| 124 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.10223502 |
| 125 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10016845 |
| 126 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09716469 |
| 127 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09456188 |
| 128 | * SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.08671124 |
| 129 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.07040040 |
| 130 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.06933377 |
| 131 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.06216075 |
| 132 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05541587 |
| 133 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.04718902 |
| 134 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04050782 |
| 135 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03706933 |
| 136 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02854136 |
| 137 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02716463 |
| 138 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02692409 |
| 139 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.02028334 |
| 140 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01908961 |
| 141 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.00388562 |
| 142 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.98845888 |
| 143 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98629679 |
| 144 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.98299242 |
| 145 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97899155 |
| 146 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97662229 |
| 147 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97507729 |
| 148 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97414958 |
| 149 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.97168423 |
| 150 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97161767 |
| 151 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.96691770 |
| 152 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.96005462 |
| 153 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95885785 |
| 154 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95668421 |
| 155 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94955210 |
| 156 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94681725 |
| 157 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94564275 |
| 158 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94548036 |
| 159 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94370149 |
| 160 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94344104 |
| 161 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.93049103 |
| 162 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92887030 |
| 163 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92037851 |
| 164 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.91791589 |
| 165 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91755657 |
| 166 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.91647970 |
| 167 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90909151 |
| 168 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90582444 |
| 169 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86706571 |
| 170 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.86610635 |
| 171 | P300_27268052_Chip-Seq_Bcells_Human | 0.85498085 |
| 172 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85062562 |
| 173 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84772512 |
| 174 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.84772286 |
| 175 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84277159 |
| 176 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.82766634 |
| 177 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.82438942 |
| 178 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81933610 |
| 179 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.81115855 |
| 180 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.79855375 |
| 181 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.79686753 |
| 182 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.79547501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.61325906 |
| 2 | MP0003195_calcinosis | 5.15686068 |
| 3 | MP0002254_reproductive_system_inflammat | 4.99426452 |
| 4 | MP0004043_abnormal_pH_regulation | 4.63843310 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 4.27962695 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 4.17438591 |
| 7 | MP0005387_immune_system_phenotype | 4.14295406 |
| 8 | MP0001790_abnormal_immune_system | 4.14295406 |
| 9 | MP0001800_abnormal_humoral_immune | 4.08189980 |
| 10 | MP0001835_abnormal_antigen_presentation | 3.78831056 |
| 11 | MP0003172_abnormal_lysosome_physiology | 3.56886884 |
| 12 | MP0005410_abnormal_fertilization | 3.24008257 |
| 13 | MP0005058_abnormal_lysosome_morphology | 3.11532667 |
| 14 | MP0003329_amyloid_beta_deposits | 3.02101820 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.99554827 |
| 16 | MP0003436_decreased_susceptibility_to | 2.95653195 |
| 17 | MP0002723_abnormal_immune_serum | 2.90409471 |
| 18 | MP0005671_abnormal_response_to | 2.87812183 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.85178249 |
| 20 | MP0001819_abnormal_immune_cell | 2.78907592 |
| 21 | MP0002638_abnormal_pupillary_reflex | 2.77517066 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.57735269 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.40371471 |
| 24 | MP0002398_abnormal_bone_marrow | 2.33754911 |
| 25 | MP0005360_urolithiasis | 2.29699823 |
| 26 | MP0005025_abnormal_response_to | 2.28303362 |
| 27 | MP0005075_abnormal_melanosome_morpholog | 2.22472274 |
| 28 | MP0000003_abnormal_adipose_tissue | 2.22243095 |
| 29 | MP0003183_abnormal_peptide_metabolism | 2.17367647 |
| 30 | MP0000716_abnormal_immune_system | 2.14690773 |
| 31 | MP0009785_altered_susceptibility_to | 2.14432256 |
| 32 | MP0010329_abnormal_lipoprotein_level | 2.10975425 |
| 33 | MP0000689_abnormal_spleen_morphology | 2.08674534 |
| 34 | MP0000604_amyloidosis | 2.07508274 |
| 35 | MP0000685_abnormal_immune_system | 2.00665777 |
| 36 | MP0002419_abnormal_innate_immunity | 1.98506028 |
| 37 | MP0002168_other_aberrant_phenotype | 1.95223130 |
| 38 | MP0005365_abnormal_bile_salt | 1.94876035 |
| 39 | MP0004381_abnormal_hair_follicle | 1.91613194 |
| 40 | MP0001764_abnormal_homeostasis | 1.76173206 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.75712792 |
| 42 | MP0005310_abnormal_salivary_gland | 1.74359763 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.73798867 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.73393525 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.71357565 |
| 46 | MP0004885_abnormal_endolymph | 1.64552935 |
| 47 | MP0002429_abnormal_blood_cell | 1.62842052 |
| 48 | MP0002722_abnormal_immune_system | 1.61744420 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.59195244 |
| 50 | MP0004130_abnormal_muscle_cell | 1.57725719 |
| 51 | MP0003724_increased_susceptibility_to | 1.57666381 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.52793993 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.51989210 |
| 54 | MP0001765_abnormal_ion_homeostasis | 1.50943063 |
| 55 | MP0003646_muscle_fatigue | 1.50725695 |
| 56 | MP0004859_abnormal_synaptic_plasticity | 1.47466708 |
| 57 | MP0001502_abnormal_circadian_rhythm | 1.45250985 |
| 58 | MP0001440_abnormal_grooming_behavior | 1.44741596 |
| 59 | MP0001853_heart_inflammation | 1.43720689 |
| 60 | MP0003690_abnormal_glial_cell | 1.39298909 |
| 61 | MP0002396_abnormal_hematopoietic_system | 1.37124380 |
| 62 | MP0000534_abnormal_ureter_morphology | 1.36262414 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.36105615 |
| 64 | MP0001873_stomach_inflammation | 1.35260812 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.34726140 |
| 66 | MP0004858_abnormal_nervous_system | 1.32395071 |
| 67 | MP0003787_abnormal_imprinting | 1.32323352 |
| 68 | MP0005332_abnormal_amino_acid | 1.32109244 |
| 69 | MP0005083_abnormal_biliary_tract | 1.31391919 |
| 70 | MP0002928_abnormal_bile_duct | 1.28825700 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 1.26461401 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.25740831 |
| 73 | MP0006138_congestive_heart_failure | 1.25081622 |
| 74 | MP0001845_abnormal_inflammatory_respons | 1.24571386 |
| 75 | MP0002405_respiratory_system_inflammati | 1.24382114 |
| 76 | MP0000372_irregular_coat_pigmentation | 1.23113449 |
| 77 | MP0002118_abnormal_lipid_homeostasis | 1.22067889 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.19199579 |
| 79 | MP0000703_abnormal_thymus_morphology | 1.19016163 |
| 80 | MP0008438_abnormal_cutaneous_collagen | 1.17975685 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17836626 |
| 82 | MP0001986_abnormal_taste_sensitivity | 1.17174202 |
| 83 | MP0003806_abnormal_nucleotide_metabolis | 1.16773630 |
| 84 | MP0001756_abnormal_urination | 1.14789389 |
| 85 | MP0002089_abnormal_postnatal_growth/wei | 1.14113496 |
| 86 | MP0005451_abnormal_body_composition | 1.12905129 |
| 87 | MP0000537_abnormal_urethra_morphology | 1.12010661 |
| 88 | MP0008874_decreased_physiological_sensi | 1.11791951 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 1.11766518 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 1.11100021 |
| 91 | MP0005275_abnormal_skin_tensile | 1.08999483 |
| 92 | MP0003252_abnormal_bile_duct | 1.08808074 |
| 93 | MP0002822_catalepsy | 1.08019549 |
| 94 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06347853 |
| 95 | MP0002896_abnormal_bone_mineralization | 1.05710016 |
| 96 | MP0005464_abnormal_platelet_physiology | 1.05497115 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 1.03377879 |
| 98 | MP0002796_impaired_skin_barrier | 1.02764187 |
| 99 | MP0004270_analgesia | 1.02731271 |
| 100 | MP0001849_ear_inflammation | 1.02708894 |
| 101 | MP0004084_abnormal_cardiac_muscle | 1.01179515 |
| 102 | MP0001533_abnormal_skeleton_physiology | 0.99669707 |
| 103 | MP0005636_abnormal_mineral_homeostasis | 0.98593742 |
| 104 | MP0008469_abnormal_protein_level | 0.98312284 |
| 105 | MP0003075_altered_response_to | 0.96463438 |
| 106 | MP0000015_abnormal_ear_pigmentation | 0.96251085 |
| 107 | MP0002876_abnormal_thyroid_physiology | 0.95115572 |
| 108 | MP0002909_abnormal_adrenal_gland | 0.94986245 |
| 109 | MP0004947_skin_inflammation | 0.94521017 |
| 110 | MP0003879_abnormal_hair_cell | 0.93448860 |
| 111 | MP0000920_abnormal_myelination | 0.93356745 |
| 112 | MP0002009_preneoplasia | 0.93327308 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 0.93147116 |
| 114 | MP0003632_abnormal_nervous_system | 0.93058174 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.92029864 |
| 116 | MP0008961_abnormal_basal_metabolism | 0.90632687 |
| 117 | MP0003698_abnormal_male_reproductive | 0.88115493 |
| 118 | MP0001663_abnormal_digestive_system | 0.87927070 |
| 119 | MP0002733_abnormal_thermal_nociception | 0.86809222 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.82114315 |
| 121 | MP0000609_abnormal_liver_physiology | 0.81253595 |
| 122 | MP0004742_abnormal_vestibular_system | 0.80312031 |
| 123 | MP0002735_abnormal_chemical_nociception | 0.80250025 |
| 124 | MP0000747_muscle_weakness | 0.79333192 |
| 125 | MP0004510_myositis | 0.79133684 |
| 126 | MP0004145_abnormal_muscle_electrophysio | 0.79124528 |
| 127 | MP0002933_joint_inflammation | 0.77836835 |
| 128 | MP0009278_abnormal_bone_marrow | 0.77370494 |
| 129 | MP0009745_abnormal_behavioral_response | 0.76851870 |
| 130 | MP0004036_abnormal_muscle_relaxation | 0.76378656 |
| 131 | MP0003631_nervous_system_phenotype | 0.75825652 |
| 132 | MP0003635_abnormal_synaptic_transmissio | 0.75509290 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.75261096 |
| 134 | MP0003633_abnormal_nervous_system | 0.74336181 |
| 135 | MP0009840_abnormal_foam_cell | 0.74230669 |
| 136 | MP0002132_abnormal_respiratory_system | 0.73224259 |
| 137 | MP0005381_digestive/alimentary_phenotyp | 0.72107181 |
| 138 | MP0009764_decreased_sensitivity_to | 0.68356409 |
| 139 | MP0001851_eye_inflammation | 0.68012568 |
| 140 | MP0005670_abnormal_white_adipose | 0.67660790 |
| 141 | MP0005395_other_phenotype | 0.66749975 |
| 142 | MP0000733_abnormal_muscle_development | 0.66436497 |
| 143 | MP0004484_altered_response_of | 0.65925490 |
| 144 | MP0000538_abnormal_urinary_bladder | 0.65483548 |
| 145 | MP0005535_abnormal_body_temperature | 0.65063949 |
| 146 | MP0010678_abnormal_skin_adnexa | 0.64727259 |
| 147 | MP0005334_abnormal_fat_pad | 0.64602368 |
| 148 | MP0003866_abnormal_defecation | 0.63904791 |
| 149 | MP0002971_abnormal_brown_adipose | 0.63310372 |
| 150 | MP0001666_abnormal_nutrient_absorption | 0.63263987 |
| 151 | MP0002272_abnormal_nervous_system | 0.62599406 |
| 152 | MP0009384_cardiac_valve_regurgitation | 0.61668753 |
| 153 | MP0000462_abnormal_digestive_system | 0.61584792 |
| 154 | MP0003634_abnormal_glial_cell | 0.61202666 |
| 155 | MP0001970_abnormal_pain_threshold | 0.60378452 |
| 156 | MP0008569_lethality_at_weaning | 0.59363840 |
| 157 | MP0000249_abnormal_blood_vessel | 0.59189122 |
| 158 | MP0005623_abnormal_meninges_morphology | 0.59174125 |
| 159 | MP0002295_abnormal_pulmonary_circulatio | 0.59101890 |
| 160 | MP0008004_abnormal_stomach_pH | 0.58390403 |
| 161 | MP0009053_abnormal_anal_canal | 0.57971356 |
| 162 | MP0004142_abnormal_muscle_tone | 0.57379769 |
| 163 | MP0003959_abnormal_lean_body | 0.56397368 |
| 164 | MP0005423_abnormal_somatic_nervous | 0.54702220 |
| 165 | MP0000751_myopathy | 0.54651569 |
| 166 | MP0004272_abnormal_basement_membrane | 0.54592222 |
| 167 | MP0002166_altered_tumor_susceptibility | 0.54464577 |
| 168 | MP0002138_abnormal_hepatobiliary_system | 0.54060162 |
| 169 | MP0002064_seizures | 0.53664659 |
| 170 | MP0005166_decreased_susceptibility_to | 0.52911217 |
| 171 | MP0001905_abnormal_dopamine_level | 0.52511965 |
| 172 | MP0008877_abnormal_DNA_methylation | 0.52282637 |
| 173 | MP0002653_abnormal_ependyma_morphology | 0.51035492 |
| 174 | MP0000013_abnormal_adipose_tissue | 0.49986512 |
| 175 | MP0004087_abnormal_muscle_fiber | 0.49664454 |
| 176 | MP0005397_hematopoietic_system_phenotyp | 0.49084653 |
| 177 | MP0003656_abnormal_erythrocyte_physiolo | 0.48675952 |
| 178 | MP0001177_atelectasis | 0.48605469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.14282558 |
| 2 | Cellulitis (HP:0100658) | 6.25643754 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.85083422 |
| 4 | Meningitis (HP:0001287) | 5.84052732 |
| 5 | Gastrointestinal stroma tumor (HP:0100723) | 5.66175752 |
| 6 | Myocardial infarction (HP:0001658) | 5.36288508 |
| 7 | Recurrent pneumonia (HP:0006532) | 5.18931963 |
| 8 | Verrucae (HP:0200043) | 5.16389447 |
| 9 | Papilloma (HP:0012740) | 5.16389447 |
| 10 | Hypophosphatemic rickets (HP:0004912) | 5.03207672 |
| 11 | Recurrent bronchitis (HP:0002837) | 4.99411482 |
| 12 | Recurrent sinusitis (HP:0011108) | 4.79125497 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.75467596 |
| 14 | Potter facies (HP:0002009) | 4.72646720 |
| 15 | Facial shape deformation (HP:0011334) | 4.72646720 |
| 16 | Vascular calcification (HP:0004934) | 4.70874042 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 4.69456752 |
| 18 | Complement deficiency (HP:0004431) | 4.64314140 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 4.44918550 |
| 20 | Obstructive lung disease (HP:0006536) | 4.44918550 |
| 21 | Cardiovascular calcification (HP:0011915) | 4.39361402 |
| 22 | Osteomyelitis (HP:0002754) | 4.38034057 |
| 23 | Neurofibrillary tangles (HP:0002185) | 4.29143264 |
| 24 | Cerebral inclusion bodies (HP:0100314) | 4.16704017 |
| 25 | Recurrent lower respiratory tract infections (HP:0002783) | 4.09370400 |
| 26 | Chronic sinusitis (HP:0011109) | 4.07203866 |
| 27 | Recurrent abscess formation (HP:0002722) | 4.06810868 |
| 28 | Abnormality of macrophages (HP:0004311) | 4.05947961 |
| 29 | Obstructive sleep apnea (HP:0002870) | 4.01378041 |
| 30 | Panhypogammaglobulinemia (HP:0003139) | 3.97455544 |
| 31 | Malnutrition (HP:0004395) | 3.93897134 |
| 32 | Recurrent fungal infections (HP:0002841) | 3.85234739 |
| 33 | Colitis (HP:0002583) | 3.77619519 |
| 34 | Inflammation of the large intestine (HP:0002037) | 3.73855602 |
| 35 | Sepsis (HP:0100806) | 3.68876098 |
| 36 | Choroideremia (HP:0001139) | 3.66675420 |
| 37 | Lymphopenia (HP:0001888) | 3.66634855 |
| 38 | Restrictive lung disease (HP:0002091) | 3.65144790 |
| 39 | Vasculitis (HP:0002633) | 3.63337743 |
| 40 | Gastrointestinal inflammation (HP:0004386) | 3.62967543 |
| 41 | Neoplasm of the heart (HP:0100544) | 3.50154822 |
| 42 | Abnormality of complement system (HP:0005339) | 3.39291713 |
| 43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.33884680 |
| 44 | IgG deficiency (HP:0004315) | 3.33526878 |
| 45 | Xanthomatosis (HP:0000991) | 3.26440962 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.22948726 |
| 47 | Recurrent viral infections (HP:0004429) | 3.20701749 |
| 48 | Deep venous thrombosis (HP:0002625) | 3.20160620 |
| 49 | Infantile muscular hypotonia (HP:0008947) | 3.18072736 |
| 50 | Supranuclear gaze palsy (HP:0000605) | 3.16255310 |
| 51 | Widely patent fontanelles and sutures (HP:0004492) | 3.15966909 |
| 52 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.14609325 |
| 53 | Rickets (HP:0002748) | 3.11958302 |
| 54 | Intention tremor (HP:0002080) | 3.10712836 |
| 55 | Broad face (HP:0000283) | 3.10244282 |
| 56 | Encephalitis (HP:0002383) | 3.08909744 |
| 57 | Recurrent skin infections (HP:0001581) | 3.01066874 |
| 58 | Choreoathetosis (HP:0001266) | 3.00131998 |
| 59 | Skin rash (HP:0000988) | 2.99081183 |
| 60 | Bronchitis (HP:0012387) | 2.98986245 |
| 61 | Agitation (HP:0000713) | 2.98913703 |
| 62 | Emphysema (HP:0002097) | 2.94419201 |
| 63 | Ketoacidosis (HP:0001993) | 2.81349723 |
| 64 | Recurrent otitis media (HP:0000403) | 2.79731800 |
| 65 | Diplopia (HP:0000651) | 2.78913965 |
| 66 | Abnormality of binocular vision (HP:0011514) | 2.78913965 |
| 67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.77020768 |
| 68 | Recurrent cutaneous fungal infections (HP:0011370) | 2.77020768 |
| 69 | Hemiplegia (HP:0002301) | 2.71014843 |
| 70 | Gastrointestinal infarctions (HP:0005244) | 2.69285098 |
| 71 | Cervical subluxation (HP:0003308) | 2.60935744 |
| 72 | Ketosis (HP:0001946) | 2.60416276 |
| 73 | IgM deficiency (HP:0002850) | 2.59472750 |
| 74 | Intrahepatic cholestasis (HP:0001406) | 2.58115806 |
| 75 | Increased IgE level (HP:0003212) | 2.58106306 |
| 76 | Prolonged bleeding time (HP:0003010) | 2.56170394 |
| 77 | Viral hepatitis (HP:0006562) | 2.56101994 |
| 78 | Lymphoma (HP:0002665) | 2.55806942 |
| 79 | Urticaria (HP:0001025) | 2.52913977 |
| 80 | B lymphocytopenia (HP:0010976) | 2.48643887 |
| 81 | Pulmonary infiltrates (HP:0002113) | 2.47568308 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.46425421 |
| 83 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.42421791 |
| 84 | Polar cataract (HP:0010696) | 2.41811756 |
| 85 | Gout (HP:0001997) | 2.41094134 |
| 86 | Difficulty running (HP:0009046) | 2.40881115 |
| 87 | Abnormality of the fovea (HP:0000493) | 2.40720225 |
| 88 | Abnormality of the peritoneum (HP:0002585) | 2.40592871 |
| 89 | Hyperglycinuria (HP:0003108) | 2.39443530 |
| 90 | Chest pain (HP:0100749) | 2.38463727 |
| 91 | Abnormality of the prostate (HP:0008775) | 2.37977489 |
| 92 | Hemorrhage of the eye (HP:0011885) | 2.37394650 |
| 93 | Pulmonary fibrosis (HP:0002206) | 2.36084141 |
| 94 | Skin ulcer (HP:0200042) | 2.35586492 |
| 95 | J-shaped sella turcica (HP:0002680) | 2.34095087 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 2.33419812 |
| 97 | Skin nodule (HP:0200036) | 2.33272204 |
| 98 | Hypopigmentation of the fundus (HP:0007894) | 2.33205749 |
| 99 | Exercise-induced myalgia (HP:0003738) | 2.32635524 |
| 100 | Stomatitis (HP:0010280) | 2.32203484 |
| 101 | Testicular atrophy (HP:0000029) | 2.27393994 |
| 102 | Hematochezia (HP:0002573) | 2.25966913 |
| 103 | Hyporeflexia of lower limbs (HP:0002600) | 2.24825315 |
| 104 | Acanthosis nigricans (HP:0000956) | 2.22869018 |
| 105 | Epidermoid cyst (HP:0200040) | 2.22532525 |
| 106 | Abnormality of purine metabolism (HP:0004352) | 2.22019289 |
| 107 | Hyperlipoproteinemia (HP:0010980) | 2.20300665 |
| 108 | Spontaneous hematomas (HP:0007420) | 2.16759989 |
| 109 | Asplenia (HP:0001746) | 2.16512126 |
| 110 | Gingivitis (HP:0000230) | 2.15826620 |
| 111 | Increased IgM level (HP:0003496) | 2.14517369 |
| 112 | Abnormal hemoglobin (HP:0011902) | 2.13973969 |
| 113 | Peripheral hypomyelination (HP:0007182) | 2.13690729 |
| 114 | Abnormality of glycine metabolism (HP:0010895) | 2.10789607 |
| 115 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.10789607 |
| 116 | Pustule (HP:0200039) | 2.10518730 |
| 117 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.07252012 |
| 118 | Hemoptysis (HP:0002105) | 2.07152789 |
| 119 | Gait ataxia (HP:0002066) | 2.06897364 |
| 120 | Osteomalacia (HP:0002749) | 2.04987617 |
| 121 | Focal segmental glomerulosclerosis (HP:0000097) | 2.03520762 |
| 122 | Myositis (HP:0100614) | 2.03269008 |
| 123 | Epistaxis (HP:0000421) | 2.02692348 |
| 124 | Hepatoblastoma (HP:0002884) | 2.02589052 |
| 125 | Spastic diplegia (HP:0001264) | 2.01987492 |
| 126 | Abnormality of T cell physiology (HP:0011840) | 2.00535692 |
| 127 | Right ventricular cardiomyopathy (HP:0011663) | 1.99932297 |
| 128 | Thin bony cortex (HP:0002753) | 1.99220548 |
| 129 | Optic neuritis (HP:0100653) | 1.96669394 |
| 130 | Retrobulbar optic neuritis (HP:0100654) | 1.96669394 |
| 131 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.96519141 |
| 132 | Abnormality of the pleura (HP:0002103) | 1.96390452 |
| 133 | Hyperammonemia (HP:0001987) | 1.96368311 |
| 134 | Leukopenia (HP:0001882) | 1.95767102 |
| 135 | Myokymia (HP:0002411) | 1.94241403 |
| 136 | Systemic lupus erythematosus (HP:0002725) | 1.94193152 |
| 137 | Abnormality of T cells (HP:0002843) | 1.92613268 |
| 138 | Hyperparathyroidism (HP:0000843) | 1.92595514 |
| 139 | Ulnar claw (HP:0001178) | 1.92470830 |
| 140 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.92006725 |
| 141 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.91755236 |
| 142 | Hypoalphalipoproteinemia (HP:0003233) | 1.91618292 |
| 143 | Dehydration (HP:0001944) | 1.91353958 |
| 144 | Episodic fever (HP:0001954) | 1.90799171 |
| 145 | Muscle fiber splitting (HP:0003555) | 1.89729103 |
| 146 | Ureteral stenosis (HP:0000071) | 1.89519091 |
| 147 | Abnormality of incisor morphology (HP:0011063) | 1.87631187 |
| 148 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87332980 |
| 149 | Hypertriglyceridemia (HP:0002155) | 1.87205026 |
| 150 | Dysostosis multiplex (HP:0000943) | 1.87151751 |
| 151 | Ectopia lentis (HP:0001083) | 1.86958826 |
| 152 | Increased connective tissue (HP:0009025) | 1.86942713 |
| 153 | Neurodegeneration (HP:0002180) | 1.85893478 |
| 154 | Ankle clonus (HP:0011448) | 1.85645874 |
| 155 | Orchitis (HP:0100796) | 1.84714449 |
| 156 | Wide cranial sutures (HP:0010537) | 1.82714083 |
| 157 | Pulmonary embolism (HP:0002204) | 1.80564195 |
| 158 | Sleep apnea (HP:0010535) | 1.80032186 |
| 159 | Hyperphosphatemia (HP:0002905) | 1.79826897 |
| 160 | Glomerulosclerosis (HP:0000096) | 1.78865666 |
| 161 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.78429876 |
| 162 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.78429876 |
| 163 | Restlessness (HP:0000711) | 1.78334179 |
| 164 | Hypophosphatemia (HP:0002148) | 1.77055208 |
| 165 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76092753 |
| 166 | Mucopolysacchariduria (HP:0008155) | 1.76092753 |
| 167 | Flared iliac wings (HP:0002869) | 1.75741153 |
| 168 | Gastrointestinal dysmotility (HP:0002579) | 1.75384716 |
| 169 | Prominent nose (HP:0000448) | 1.75083933 |
| 170 | Severe visual impairment (HP:0001141) | 1.74137149 |
| 171 | Amyloidosis (HP:0011034) | 1.73194947 |
| 172 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.72775383 |
| 173 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.72775383 |
| 174 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.72775383 |
| 175 | Psychosis (HP:0000709) | 1.72187676 |
| 176 | Turricephaly (HP:0000262) | 1.71829907 |
| 177 | Increased CSF protein (HP:0002922) | 1.71085590 |
| 178 | Pili torti (HP:0003777) | 1.70846619 |
| 179 | Oligomenorrhea (HP:0000876) | 1.69930446 |
| 180 | Progressive neurologic deterioration (HP:0002344) | 1.67885563 |
| 181 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.67554521 |
| 182 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.66861012 |
| 183 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.65948481 |
| 184 | Hyperglycinemia (HP:0002154) | 1.65058797 |
| 185 | Abnormal cartilage morphology (HP:0002763) | 1.64723552 |
| 186 | Abnormality of the Achilles tendon (HP:0005109) | 1.64570001 |
| 187 | Tubulointerstitial fibrosis (HP:0005576) | 1.64304893 |
| 188 | Abnormality of the periventricular white matter (HP:0002518) | 1.63773822 |
| 189 | Back pain (HP:0003418) | 1.61781512 |
| 190 | Calf muscle hypertrophy (HP:0008981) | 1.61100706 |
| 191 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.56883717 |
| 192 | Prominent forehead (HP:0011220) | 1.56679663 |
| 193 | Abnormality of the common coagulation pathway (HP:0010990) | 1.56455929 |
| 194 | Subcapsular cataract (HP:0000523) | 1.56385669 |
| 195 | Abnormality of abdominal situs (HP:0011620) | 1.55309656 |
| 196 | Abdominal situs inversus (HP:0003363) | 1.55309656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.31761433 |
| 2 | SIK3 | 3.77368008 |
| 3 | BLK | 3.76440981 |
| 4 | MST4 | 3.59951439 |
| 5 | ERN1 | 3.33864879 |
| 6 | IRAK4 | 3.17206365 |
| 7 | LMTK2 | 3.14510893 |
| 8 | NME2 | 2.92807074 |
| 9 | EPHB1 | 2.83438921 |
| 10 | GRK6 | 2.82281673 |
| 11 | MAP3K10 | 2.77202241 |
| 12 | SIK1 | 2.66586393 |
| 13 | PKN2 | 2.52488728 |
| 14 | BMPR2 | 2.43575264 |
| 15 | LRRK2 | 2.31302345 |
| 16 | TXK | 2.27511159 |
| 17 | PDGFRA | 2.17868256 |
| 18 | TRIB3 | 2.16866117 |
| 19 | FGFR2 | 2.15081399 |
| 20 | FER | 2.13478969 |
| 21 | BTK | 2.09390149 |
| 22 | TYK2 | 2.01095350 |
| 23 | FGFR4 | 1.98138945 |
| 24 | SYK | 1.95735735 |
| 25 | PRPF4B | 1.91689423 |
| 26 | TAOK3 | 1.87208353 |
| 27 | MAP3K11 | 1.84184532 |
| 28 | STK39 | 1.82976106 |
| 29 | MAPK12 | 1.80970309 |
| 30 | WNK4 | 1.78902714 |
| 31 | PRKD3 | 1.78601196 |
| 32 | MARK3 | 1.62485897 |
| 33 | MAP3K2 | 1.56262119 |
| 34 | LYN | 1.54873054 |
| 35 | PTK6 | 1.54310193 |
| 36 | MARK2 | 1.51559270 |
| 37 | PKN1 | 1.48235534 |
| 38 | EPHA2 | 1.47428768 |
| 39 | KIT | 1.42989202 |
| 40 | TNK2 | 1.40251337 |
| 41 | TTN | 1.39070565 |
| 42 | RET | 1.36773329 |
| 43 | MAP2K3 | 1.36499894 |
| 44 | NTRK3 | 1.35755759 |
| 45 | TYRO3 | 1.29813479 |
| 46 | PTK2B | 1.29668404 |
| 47 | PRKD2 | 1.26389725 |
| 48 | NTRK1 | 1.25782096 |
| 49 | ZAP70 | 1.25705507 |
| 50 | PAK3 | 1.24522898 |
| 51 | RIPK4 | 1.21963575 |
| 52 | PTK2 | 1.20553437 |
| 53 | MAP2K4 | 1.20516811 |
| 54 | MYLK | 1.16089345 |
| 55 | MAPK11 | 1.15722739 |
| 56 | IKBKE | 1.14700239 |
| 57 | TAOK1 | 1.13170515 |
| 58 | INSR | 1.11891536 |
| 59 | CDK19 | 1.09669583 |
| 60 | KSR2 | 1.09137451 |
| 61 | LCK | 1.08729325 |
| 62 | SCYL2 | 1.08100749 |
| 63 | TESK1 | 1.07721185 |
| 64 | IKBKB | 1.07548835 |
| 65 | PRKCH | 1.07423846 |
| 66 | STK10 | 1.06870386 |
| 67 | PAK6 | 1.06766835 |
| 68 | TBK1 | 1.06460945 |
| 69 | BCKDK | 1.05971449 |
| 70 | CSF1R | 1.05012575 |
| 71 | MAPK13 | 0.99016890 |
| 72 | FRK | 0.98598047 |
| 73 | FGFR3 | 0.98332504 |
| 74 | TAOK2 | 0.96629308 |
| 75 | ITK | 0.96623839 |
| 76 | JAK3 | 0.96545161 |
| 77 | CDC42BPA | 0.92005449 |
| 78 | MAP3K7 | 0.89991920 |
| 79 | LATS2 | 0.88969083 |
| 80 | HCK | 0.88458639 |
| 81 | PASK | 0.87073877 |
| 82 | DMPK | 0.86286355 |
| 83 | EPHB2 | 0.85753407 |
| 84 | ICK | 0.83801078 |
| 85 | MAP3K6 | 0.83618320 |
| 86 | FGR | 0.82811882 |
| 87 | TESK2 | 0.82692219 |
| 88 | CDK5 | 0.82018098 |
| 89 | MAP3K3 | 0.82000252 |
| 90 | MAPK15 | 0.81451967 |
| 91 | PAK4 | 0.80963356 |
| 92 | PAK2 | 0.79494714 |
| 93 | ALK | 0.78825772 |
| 94 | EPHA4 | 0.78493482 |
| 95 | SIK2 | 0.77299750 |
| 96 | MAP3K12 | 0.76998019 |
| 97 | PDK3 | 0.73980160 |
| 98 | PDK4 | 0.73980160 |
| 99 | OBSCN | 0.72798593 |
| 100 | MAP2K1 | 0.72679812 |
| 101 | NTRK2 | 0.71358329 |
| 102 | DAPK2 | 0.70775878 |
| 103 | MINK1 | 0.69888269 |
| 104 | PHKG2 | 0.69484540 |
| 105 | PHKG1 | 0.69484540 |
| 106 | WNK1 | 0.69483179 |
| 107 | CAMK1G | 0.68829103 |
| 108 | PRKCG | 0.68504100 |
| 109 | DDR2 | 0.67772993 |
| 110 | JAK2 | 0.66869046 |
| 111 | TEC | 0.65927999 |
| 112 | GSK3A | 0.65212432 |
| 113 | ROCK2 | 0.63688213 |
| 114 | FGFR1 | 0.63515315 |
| 115 | FLT3 | 0.63345870 |
| 116 | STK38 | 0.62999070 |
| 117 | LATS1 | 0.61943507 |
| 118 | NLK | 0.61408511 |
| 119 | SRC | 0.61010959 |
| 120 | AKT3 | 0.60916994 |
| 121 | PDGFRB | 0.59639288 |
| 122 | FYN | 0.58401041 |
| 123 | PRKD1 | 0.58253348 |
| 124 | UHMK1 | 0.57090450 |
| 125 | EEF2K | 0.56414160 |
| 126 | MAPK4 | 0.56408229 |
| 127 | PRKCZ | 0.56035244 |
| 128 | STK11 | 0.55696456 |
| 129 | CDK4 | 0.54914954 |
| 130 | PRKACG | 0.54732076 |
| 131 | DYRK1B | 0.54531868 |
| 132 | MAP3K1 | 0.53459703 |
| 133 | CAMKK1 | 0.52854363 |
| 134 | FES | 0.52226346 |
| 135 | MET | 0.51474938 |
| 136 | MAP3K9 | 0.51392403 |
| 137 | MARK1 | 0.50989377 |
| 138 | ERBB2 | 0.50751596 |
| 139 | KDR | 0.50080713 |
| 140 | CSNK1E | 0.50068725 |
| 141 | CDK6 | 0.49259929 |
| 142 | EGFR | 0.47742552 |
| 143 | CAMK2B | 0.47527261 |
| 144 | MAP3K14 | 0.47356402 |
| 145 | PRKCQ | 0.46328144 |
| 146 | PIM1 | 0.44855454 |
| 147 | TLK1 | 0.44383887 |
| 148 | PDK1 | 0.43301182 |
| 149 | CSK | 0.43216451 |
| 150 | RIPK1 | 0.42593388 |
| 151 | MAP3K13 | 0.42246694 |
| 152 | CAMK1 | 0.41492299 |
| 153 | JAK1 | 0.41358785 |
| 154 | HIPK2 | 0.41220261 |
| 155 | PDPK1 | 0.40003897 |
| 156 | MAP3K4 | 0.39821385 |
| 157 | DAPK3 | 0.38764402 |
| 158 | MAPKAPK2 | 0.37525834 |
| 159 | PRKAA1 | 0.37204774 |
| 160 | ARAF | 0.36392795 |
| 161 | MAP2K2 | 0.34253425 |
| 162 | IRAK2 | 0.32890434 |
| 163 | ABL1 | 0.31089868 |
| 164 | PRKCD | 0.30745483 |
| 165 | PINK1 | 0.29296324 |
| 166 | ILK | 0.28522438 |
| 167 | MAPK3 | 0.27755566 |
| 168 | DAPK1 | 0.27267254 |
| 169 | MELK | 0.27079195 |
| 170 | MAP2K6 | 0.26644675 |
| 171 | MAP3K5 | 0.24845585 |
| 172 | RPS6KA6 | 0.24290037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.23860510 |
| 2 | Glutathione metabolism_Homo sapiens_hsa00480 | 4.22622221 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.14171967 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.06039852 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.86881234 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.82978838 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.78776296 |
| 8 | Asthma_Homo sapiens_hsa05310 | 3.76195274 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.50534210 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 3.48092641 |
| 11 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 3.39281931 |
| 12 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 3.35169113 |
| 13 | African trypanosomiasis_Homo sapiens_hsa05143 | 3.22019666 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.06883229 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.98170582 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86594029 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85215301 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.42969212 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 2.29325894 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.21492742 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.00543428 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.99894132 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96579047 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.94392273 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.94224469 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.88588904 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.78886985 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.64896263 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63488174 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.63167462 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56219690 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.54302013 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53643301 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53329075 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.44075742 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.38970786 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32778814 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31403819 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30385010 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.28903986 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 1.27766195 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.22432177 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20116380 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.17591483 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17531621 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17057257 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.14904180 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.14353210 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10056412 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09325774 |
| 51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03310432 |
| 52 | Morphine addiction_Homo sapiens_hsa05032 | 1.02490029 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01718619 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01262163 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.00538966 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.99932007 |
| 57 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.99675627 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.99381635 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98346842 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97196085 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.96996836 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.96640648 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96591027 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.95919754 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94371781 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93425652 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92506947 |
| 68 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.90868751 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90858788 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89172868 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88618315 |
| 72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88382570 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87428187 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.87139665 |
| 75 | GABAergic synapse_Homo sapiens_hsa04727 | 0.85497810 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83077015 |
| 77 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82897118 |
| 78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80694064 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79063124 |
| 80 | Measles_Homo sapiens_hsa05162 | 0.78549654 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74806303 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73828378 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73050621 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72858975 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72395380 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.70908969 |
| 87 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69898854 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.69332982 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68467943 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.66663768 |
| 91 | Circadian entrainment_Homo sapiens_hsa04713 | 0.66526621 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64967021 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64908101 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63688850 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62789399 |
| 96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62695990 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62088254 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62086784 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.61189964 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60908445 |
| 101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.59358812 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58486732 |
| 103 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58170679 |
| 104 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57353170 |
| 105 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55733331 |
| 106 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55307053 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53993359 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.53989454 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53615489 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53552288 |
| 111 | Hepatitis B_Homo sapiens_hsa05161 | 0.52483385 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52019451 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.51652829 |
| 114 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51315757 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50562218 |
| 116 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.49799155 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49290130 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48443468 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.48131164 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47281719 |
| 121 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46444702 |
| 122 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46047779 |
| 123 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45760845 |
| 124 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.44641008 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44330184 |
| 126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43973585 |
| 127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43878076 |
| 128 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.43559076 |
| 129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43416053 |
| 130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42958670 |
| 131 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41182745 |
| 132 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41065152 |
| 133 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40975843 |
| 134 | Insulin secretion_Homo sapiens_hsa04911 | 0.40412415 |
| 135 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39866329 |
| 136 | Shigellosis_Homo sapiens_hsa05131 | 0.38270482 |
| 137 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37678165 |
| 138 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.37346690 |
| 139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37150022 |
| 140 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.36625340 |
| 141 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36597434 |
| 142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36066970 |
| 143 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35550459 |
| 144 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35070435 |
| 145 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34615328 |
| 146 | Pertussis_Homo sapiens_hsa05133 | 0.34607205 |
| 147 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34560720 |
| 148 | Phototransduction_Homo sapiens_hsa04744 | 0.34133801 |
| 149 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34085019 |
| 150 | ABC transporters_Homo sapiens_hsa02010 | 0.33422289 |
| 151 | Glioma_Homo sapiens_hsa05214 | 0.32939929 |
| 152 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.32879137 |
| 153 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31862520 |
| 154 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.31587142 |
| 155 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.31582475 |
| 156 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.31071451 |
| 157 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30872401 |
| 158 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29770167 |
| 159 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29701832 |
| 160 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28512124 |
| 161 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.27951938 |
| 162 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.27013826 |
| 163 | Insulin resistance_Homo sapiens_hsa04931 | 0.26886651 |
| 164 | Melanogenesis_Homo sapiens_hsa04916 | 0.26182483 |
| 165 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.25702575 |
| 166 | Olfactory transduction_Homo sapiens_hsa04740 | 0.24550854 |
| 167 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.24034041 |
| 168 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23955235 |
| 169 | Apoptosis_Homo sapiens_hsa04210 | 0.23691997 |
| 170 | Cocaine addiction_Homo sapiens_hsa05030 | 0.23202256 |
| 171 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23168933 |
| 172 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22710951 |
| 173 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22568776 |

